Wim Jiskoot
Wim Jiskoot
Leiden University, Coriolis Pharma
Verified email at lacdr.leidenuniv.nl
TitleCited byYear
Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates
V Filipe, A Hawe, W Jiskoot
Pharmaceutical research 27 (5), 796-810, 2010
11762010
Extrinsic fluorescent dyes as tools for protein characterization
A Hawe, M Sutter, W Jiskoot
Pharmaceutical research 25 (7), 1487-1499, 2008
8862008
Protein instability in poly (lactic-co-glycolic acid) microparticles
M van de Weert, WE Hennink, W Jiskoot
Pharmaceutical research 17 (10), 1159-1167, 2000
7492000
Structure-immunogenicity relationships of therapeutic proteins
S Hermeling, DJA Crommelin, H Schellekens, W Jiskoot
Pharmaceutical research 21 (6), 897-903, 2004
5932004
Chitosan-based delivery systems for protein therapeutics and antigens
M Amidi, E Mastrobattista, W Jiskoot, WE Hennink
Advanced drug delivery reviews 62 (1), 59-82, 2010
5522010
Identification of formaldehyde-induced modifications in proteins reactions with model peptides
B Metz, GFA Kersten, P Hoogerhout, HF Brugghe, HAM Timmermans, ...
Journal of Biological Chemistry 279 (8), 6235-6243, 2004
5332004
Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality
JF Carpenter, TW Randolph, WIM Jiskoot, DJA Crommelin, CR Middaugh, ...
Journal of pharmaceutical sciences 98 (4), 1201-1205, 2009
4502009
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system
M Amidi, SG Romeijn, G Borchard, HE Junginger, WE Hennink, W Jiskoot
Journal of controlled release 111 (1-2), 107-116, 2006
4132006
Microneedle technologies for (trans) dermal drug and vaccine delivery
K van der Maaden, W Jiskoot, J Bouwstra
Journal of controlled release 161 (2), 645-655, 2012
3712012
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity
MI De Jonge, G Pehau-Arnaudet, MM Fretz, F Romain, D Bottai, P Brodin, ...
Journal of bacteriology 189 (16), 6028-6034, 2007
2822007
N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model
M Amidi, SG Romeijn, JC Verhoef, HE Junginger, L Bungener, ...
Vaccine 25 (1), 144-153, 2007
2482007
Shifting paradigms: biopharmaceuticals versus low molecular weight drugs
DJA Crommelin, G Storm, R Verrijk, L de Leede, W Jiskoot, WE Hennink
International journal of pharmaceutics 266 (1-2), 3-16, 2003
2292003
Antibody response to aggregated human interferon alpha2b in wild‐type and transgenic immune tolerant mice depends on type and level of aggregation
S Hermeling, H Schellekens, C Maas, MFBG Gebbink, DJA Crommelin, ...
Journal of pharmaceutical sciences 95 (5), 1084-1096, 2006
2272006
Strategies for the assessment of protein aggregates in pharmaceutical biotech product development
J Den Engelsman, P Garidel, R Smulders, H Koll, B Smith, S Bassarab, ...
Pharmaceutical research 28 (4), 920-933, 2011
2202011
Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins
E Mastrobattista, GA Koning, L van Bloois, ACS Filipe, W Jiskoot, G Storm
Journal of Biological Chemistry 277 (30), 27135-27143, 2002
2172002
Synthesis, characterization and in vitro biological properties of O-methyl free N, N, N-trimethylated chitosan
RJ Verheul, M Amidi, S van der Wal, E van Riet, W Jiskoot, WE Hennink
Biomaterials 29 (27), 3642-3649, 2008
1932008
Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition
C Foged, C Arigita, A Sundblad, W Jiskoot, G Storm, S Frokjaer
Vaccine 22 (15-16), 1903-1913, 2004
1912004
Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination
B Slütter, L Plapied, V Fievez, MA Sande, A des Rieux, YJ Schneider, ...
Journal of Controlled Release 138 (2), 113-121, 2009
1882009
Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release
W Jiskoot, TW Randolph, DB Volkin, CR Middaugh, C Schöneich, ...
Journal of pharmaceutical sciences 101 (3), 946-954, 2012
1852012
Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
SM Bal, Z Ding, E van Riet, W Jiskoot, JA Bouwstra
Journal of controlled release 148 (3), 266-282, 2010
1842010
The system can't perform the operation now. Try again later.
Articles 1–20